Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $172.10B
Liabilities Breakdown FY2013
Total Liabilities: $95.48B
Asset Breakdown
Total Assets: $172.10B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.18B | 1.3% |
| Accounts Receivable | $9.36B | 5.4% |
| Inventory | $6.17B | 3.6% |
| Property, Plant & Equipment | $12.40B | 7.2% |
| Goodwill | $42.52B | 24.7% |
| Intangible Assets | $39.39B | 22.9% |
| Other Assets | $60.09B | 34.9% |
Liabilities Breakdown
Total Liabilities: $95.48B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.23B | 3.4% |
| Long-Term Debt | $30.46B | 31.9% |
| Other Liabilities | $61.79B | 64.7% |